CRBP Price Targets and Analyst Ratings NASDAQ:CRBP
CRBP Forecast. What You Should Know.
CRBP Historical Ratings and Targets
About Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.